SUMAVEL DOSEPRO Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Sumavel Dosepro, and when can generic versions of Sumavel Dosepro launch?

Sumavel Dosepro is a drug marketed by Endo Operations and is included in one NDA. There are three patents protecting this drug.

This drug has fourteen patent family members in eight countries.

The generic ingredient in SUMAVEL DOSEPRO is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Sumavel Dosepro

A generic version of SUMAVEL DOSEPRO was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6^th, 2009.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for SUMAVEL DOSEPRO?
What are the global sales for SUMAVEL DOSEPRO?
What is Average Wholesale Price for SUMAVEL DOSEPRO?

Summary for SUMAVEL DOSEPRO

International Patents:	14
US Patents:	3
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	115
Clinical Trials:	1
Patent Applications:	2,223
Drug Prices:	Drug price information for SUMAVEL DOSEPRO
What excipients (inactive ingredients) are in SUMAVEL DOSEPRO?	SUMAVEL DOSEPRO excipients list
DailyMed Link:	SUMAVEL DOSEPRO at DailyMed

Drug patent expirations by year for SUMAVEL DOSEPRO

Recent Clinical Trials for SUMAVEL DOSEPRO

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Synteract, Inc.	Phase 4
Zogenix, Inc.	Phase 4

See all SUMAVEL DOSEPRO clinical trials

US Patents and Regulatory Information for SUMAVEL DOSEPRO

SUMAVEL DOSEPRO is protected by three US patents.

Patents protecting SUMAVEL DOSEPRO

Device for readying a needle free injector for delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Casing
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Device for readying a needle free injector for delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-002	Nov 26, 2013		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for SUMAVEL DOSEPRO

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009	⤷ Sign Up	⤷ Sign Up
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009	⤷ Sign Up	⤷ Sign Up
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009	⤷ Sign Up	⤷ Sign Up
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009	⤷ Sign Up	⤷ Sign Up
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009	⤷ Sign Up	⤷ Sign Up
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009	⤷ Sign Up	⤷ Sign Up
Endo Operations	SUMAVEL DOSEPRO	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	022239-001	Jul 15, 2009	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for SUMAVEL DOSEPRO

See the table below for patents covering SUMAVEL DOSEPRO around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	1097727		⤷ Sign Up
Germany	60214870		⤷ Sign Up
Australia	2003219086	NOVEL DEVICE	⤷ Sign Up
Spain	2191822		⤷ Sign Up
Denmark	0892736		⤷ Sign Up
United Kingdom	9525757		⤷ Sign Up
Brazil	9607219		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for SUMAVEL DOSEPRO

Recent Clinical Trials for SUMAVEL DOSEPRO

Patents protecting SUMAVEL DOSEPRO

Make Better Decisions: Try a trial or see plans & pricing